ucb sa (UCB:Euronext Brussels)
Ismail Kola Ph.D.
Chief Scientific Officer, Head of New Medicines Patient Value Unit and Executive Vice President, UCB S.A.
|Age||Total Calculated Compensation||This person is connected to 65 board members in 6 different organizations across 8 different industries.|
See Board Relationships
Dr. Ismail Kola, Ph.D., has been the Chief Scientific Officer and Head of New Medicines Patient Value Unit at UCB S.A., since February 2015. Dr. Kola has been an Executive Vice President of UCB SA since November 23, 2009. Dr. Kola served as President of UCB New Medicines(TM) for UCB SA since November 23, 2009. He served as the President of UCB NewMedicines at Kremers Urban Pharmaceuticals Inc. He served as Executive Vice President of UCB Newmedicines (TM) at Ucb S.A. ...
Allée de la Recherche, 60Phone: 32 2 559 99 99
Brussels, Brussels 1070
Fax: 32 2 559 99 00
Board Members Memberships*
Non Executive Director
Director and Member of Nominations & Corporate Governance Committee
Director and Member of Governance & Nominating Committee
Director and Member of Nomination & Remuneration Committee
University of Cape Town
University of South Africa
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Rajiv Kanishka Liyanaarchchie De Silva||Chief Executive Officer, President and Director|
Endo International plc
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Richard Ridinger||Chief Executive Officer|
Lonza Group Ltd
|Victor Grifols Roura||Chairman, Chief Executive Officer, President and Member of Appointments & Remuneration Committee|
|F. Michael Ball||Chief Executive Officer, Director and Member of Science & Technology Committee|
|$1.1M||Compensation as of Fiscal Year 2014.|